Steward Partners Investment Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.8M | Buy |
79,642
+2,737
| +4% | +$937K | 0.15% | 138 |
|
|
2026
Q1 | $27.1M | Sell |
76,905
-4,700
| -6% | -$1.68M | 0.14% | 131 |
|
|
2025
Q4 | $26.7M | Buy |
81,605
+3,610
| +5% | +$1.15M | 0.15% | 127 |
|
|
2025
Q3 | $22M | Buy |
77,995
+2,497
| +3% | +$724K | 0.13% | 148 |
|
|
2025
Q2 | $21.1M | Buy |
75,498
+1,535
| +2% | +$435K | 0.16% | 122 |
|
|
2025
Q1 | $23M | Sell |
73,963
-1,196
| -2% | -$353K | 0.2% | 100 |
|
|
2024
Q4 | $19.6M | Sell |
75,159
-9,963
| -12% | -$2.96M | 0.17% | 116 |
|
|
2024
Q3 | $27.4M | Buy |
85,122
+11,571
| +16% | +$3.78M | 0.25% | 86 |
|
|
2024
Q2 | $23M | Buy |
73,551
+1,755
| +2% | +$516K | 0.24% | 88 |
|
|
2024
Q1 | $20.4M | Buy |
71,796
+1,237
| +2% | +$362K | 0.23% | 88 |
|
|
2023
Q4 | $20.3M | Buy |
70,559
+3,077
| +5% | +$838K | 0.27% | 76 |
|
|
2023
Q3 | $18.1M | Buy |
67,482
+11,496
| +21% | +$2.87M | 0.28% | 75 |
|
|
2023
Q2 | $12.4M | Sell |
55,986
-158
| -0.3% | -$36.7K | 0.19% | 118 |
|
|
2023
Q1 | $13.6M | Buy |
56,144
+1,307
| +2% | +$321K | 0.22% | 105 |
|
|
2022
Q4 | $14.4M | Sell |
54,837
-1,521
| -3% | -$408K | 0.25% | 99 |
|
|
2022
Q3 | $12.7M | Buy |
56,358
+673
| +1% | +$163K | 0.24% | 98 |
|
|
2022
Q2 | $13.5M | Sell |
55,685
-824
| -1% | -$202K | 0.25% | 98 |
|
|
2022
Q1 | $13.7M | Buy |
56,509
+6,159
| +12% | +$1.42M | 0.21% | 114 |
|
|
2021
Q4 | $11.3M | Sell |
50,350
-530
| -1% | -$112K | 0.17% | 136 |
|
|
2021
Q3 | $10.8M | Sell |
50,880
-9,110
| -15% | -$2.1M | 0.19% | 131 |
|
|
2021
Q2 | $14.6M | Sell |
59,990
-9,998
| -14% | -$2.46M | 0.25% | 92 |
|
|
2021
Q1 | $17.4M | Buy |
69,988
+5,284
| +8% | +$1.26M | 0.31% | 72 |
|
|
2020
Q4 | $14.9M | Buy |
64,704
+575
| +0.9% | +$133K | 0.32% | 68 |
|
|
2020
Q3 | $16.3M | Buy |
64,129
+5,332
| +9% | +$1.32M | 0.41% | 54 |
|
|
2020
Q2 | $13.9M | Buy |
58,797
+20,793
| +55% | +$4.74M | 0.4% | 58 |
|
|
2020
Q1 | $7.7M | Sell |
38,004
-1,503
| -4% | -$328K | 0.28% | 92 |
|
|
2019
Q4 | $9.52M | Buy |
39,507
+411
| +1% | +$90.6K | 0.28% | 85 |
|
|
2019
Q3 | $7.57M | Buy |
39,096
+1,395
| +4% | +$268K | 0.25% | 93 |
|
|
2019
Q2 | $6.95M | Sell |
37,701
-462
| -1% | -$82.7K | 0.26% | 95 |
|
|
2019
Q1 | $7.25M | Sell |
38,163
-28
| -0.1% | -$5.35K | 0.31% | 81 |
|
|
2018
Q4 | $7.43M | Buy |
38,191
+611
| +2% | +$119K | 0.36% | 73 |
|
|
2018
Q3 | $7.79M | Sell |
37,580
-562
| -1% | -$111K | 0.37% | 63 |
|
|
2018
Q2 | $7.04M | Buy |
38,142
+9,698
| +34% | +$1.72M | 0.42% | 48 |
|
|
2018
Q1 | $4.85M | Buy |
28,444
+181
| +0.6% | +$33.2K | 0.33% | 76 |
|
|
2017
Q4 | $4.92M | Buy |
28,263
+1,508
| +6% | +$267K | 0.38% | 62 |
|
|
2017
Q3 | $4.99M | Buy |
26,755
+3,611
| +16% | +$640K | 0.51% | 50 |
|
|
2017
Q2 | $3.99M | Buy |
23,144
+5,262
| +29% | +$856K | 0.45% | 58 |
|
|
2017
Q1 | $2.93M | Buy |
17,882
+8,678
| +94% | +$1.44M | 0.44% | 60 |
|
|
2016
Q4 | $1.34M | Buy |
+9,204
| New | +$1.39M | 0.61% | 34 |
|
Other funds holding AMGN
Steward Partners Investment Advisory's AMGN Position: Q2 2026 in Review
Steward Partners Investment Advisory increased its Amgen (AMGN) stake by 3.6% in Q2 2026, buying an estimated $937K and bringing the position to 79,642 shares worth $28.8M. The position accounts for 0.15% of the portfolio, ranked #138.
Steward Partners Investment Advisory first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Steward Partners Investment Advisory held 79,642 shares of Amgen worth $28.8M as of Q2 2026.
- Steward Partners Investment Advisory bought 2,737 Amgen shares in Q2 2026, an estimated $937K.
- Amgen made up 0.15% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #138 holding.
- Steward Partners Investment Advisory first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.